Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
about
Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic reviewProkinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis.Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteriaProton pump inhibitors for functional dyspepsia.Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study.Overlap between postprandial distress and epigastric pain syndromes in functional dyspepsia: its implications for research and clinical practice (am j gastroenterol 2013;108:767-774)Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia.ACG and CAG Clinical Guideline: Management of Dyspepsia.Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria.The effect of levosulpiride on in vitro motor patterns in the human gastric fundus, antrum, and jejunum.Mosapride treatment for functional dyspepsia: a meta-analysis.
P2860
Q27026890-D2EE1259-8CCD-409F-AA26-B73A5022902DQ33836928-AC2469AC-311D-4B14-AB93-747FD1819AB3Q36054184-787136DF-A69C-4A17-96F1-62CC38C27728Q36150051-48A5557E-7D1A-4E11-8E73-CB72D5BC5C06Q36300366-6BEB16FE-1FF0-400A-ACF6-D15BD7C56841Q36762648-34328067-D366-4F83-BD07-E469F7AEAE5EQ37022383-CAB14486-F584-49D8-A4BC-9498F3D47C73Q38080665-17ED16DD-1A2A-44B7-BB1F-0EAC82E19CCAQ38233254-B310EAD2-0721-4905-8999-D04AB8FAA6A7Q39385451-5B694EB6-4397-49A3-93FC-EED4C75DFDF9Q44893628-E72146A2-2303-4B52-85E5-0EB35FE652F2Q50263190-6DE79338-5AEE-473C-9E42-50EFE3AC2A68Q53149792-53CA5F77-6553-4B93-934C-D92DF160A658
P2860
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@en
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@nl
type
label
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@en
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@nl
prefLabel
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@en
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@nl
P2093
P2860
P1476
Proton pump inhibitor versus p ...... edicted by Rome III subgroups?
@en
P2093
Hsiu-Po Wang
Huei-Tang Wu
Hwai-Jeng Lin
Jaw-Town Lin
Ming-Shiang Wu
Tzeng-Huey Yang
Wei-Lun Hsu
Yao-Chun Hsu
P2860
P304
P356
10.1007/S00535-010-0334-1
P577
2010-10-19T00:00:00Z